Archives
-
HDAC Inhibitors Repress NUT Function in NUT Carcinoma
2026-10-07
Shiota et al. developed a dCas9-based reporter screen that identified structurally diverse HDAC inhibitors as repressors of NUT transcriptional activity. The findings connect HDAC inhibition with reduced BRD4-NUT megadomain activity, oncogenic transcriptional suppression, cellular differentiation, and tumor-growth control, while also highlighting important limits on translating these observations into treatment claims.
-
PP 1 and Src Kinase Signaling: Evidence and Limits
2026-10-06
PP 1 is a research small molecule used to interrogate Src-family kinase signaling, including Lck, Fyn and related pathways. This overview separates supplier-described properties from peer-reviewed findings, explains conceptual applications in cancer and immunology research, and compares the evidence with a study linking ibrutinib-associated atrial fibrillation to off-target C-terminal Src kinase inhibition.
-
Sodium Chloride B7288: Product Overview
2026-10-06
Sodium chloride (NaCl), SKU B7288, is an inorganic salt listed for conceptual use in aqueous buffer preparation, ionic strength control, osmotic balance, and selected cell culture media contexts. No matched paper evidence is available for application-specific performance.
-
GSK-923295 and CENP-E in Mitotic Fidelity
2026-10-05
GSK-923295 is a small-molecule CENP-E inhibitor described by APExBIO as a tool for studying chromosome alignment, mitotic arrest, and tumor-cell responses. The supplied Walsh et al. study addresses a related but distinct question: how CTCF maintains centromere structure and mitotic fidelity. Together, the evidence supports a useful conceptual distinction between CENP-E-dependent chromosome congression and CTCF-dependent centromere architecture, while remaining insufficient to establish a direct mechanistic or therapeutic relationship between the two targets.
-
Multi-Node PI3K/AKT/mTOR Inhibition in Cancer Models
2026-10-05
A 2025 British Journal of Cancer study shows that simultaneous inhibition of PI3Kα, mTORC1, and mTORC2 can suppress pathway signaling more broadly than single-node approaches in endometrial and breast cancer models. Its strongest preclinical result was observed when this strategy was combined with paclitaxel and an insulin-suppressing diet, although the findings remain limited to laboratory and xenograft systems.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-10-04
A 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to connect the glucose-poor, hypoxic primary CNS lymphoma microenvironment with SLC2A5-mediated fructose metabolism. Functional perturbation results suggest that SLC2A5 may represent a metabolic vulnerability spanning malignant cells and tumor-supportive macrophages, although clinical applicability remains unestablished.
-
PKH26 Red Fluorescent Cell Linker Kit Overview
2026-10-03
The PKH26 Red Fluorescent Cell Linker Kit (SKU K2410) is listed by APExBIO as a membrane-labeling product for conceptual cell tracing and proliferation studies. No matched paper evidence was provided, so performance claims remain supplier-reported and un independently validated.
-
Morning Endurance Training Improves Mouse Adaptation
2026-10-02
This study shows that training during the early active phase produces greater endurance improvement than late-active-phase training in female mice, even when the early-phase group performs less absolute work. The findings position exercise timing as a determinant of training efficiency and provide a framework for interpreting circadian effects on muscle metabolism, glycogen handling, and mitochondrial adaptation.
-
Immunodominant P. vivax Epitopes for Surveillance
2026-10-01
A 2026 study integrated computational antigen prioritization, peptide serology, multiplex validation, and sequence conservation analysis to identify immunodominant B-cell epitopes for Plasmodium vivax surveillance. Four candidates showed strong species-discriminating performance, while MSP9₃₈₄–₃₈₉ provided a signal associated with asymptomatic infection, highlighting a potential route toward more precise detection of hidden malaria reservoirs.
-
ATS-9R/siCcl2 Targeting in GDM
2026-10-01
The reference study develops an ATS-9R/siCcl2 strategy to deliver Ccl2 siRNA to adipose tissue macrophages in gestational diabetes mellitus. Its findings connect targeted macrophage gene silencing with reduced adipose inflammation and improved insulin resistance, while also identifying ER–mitochondrial calcium transport and reactive oxygen species as relevant mechanisms.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-30
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at markedly lower concentrations than wild-type yeast. The system identified known catalytic inhibitors and aminophylline as TOR1-dependent growth inhibitors while finding no evidence of TOR inhibition for Canagliflozin and several other test compounds.
-
Canagliflozin: A Rigorous Assay-Control Strategy
2026-09-30
Canagliflozin hemihydrate is a powerful tool for glucose metabolism research, but its value extends beyond SGLT2 pharmacology. This article explains how a drug-sensitized yeast study supports rigorous negative-control design when evaluating possible mTOR activity.
-
Resazurin sodium salt for Reliable Cell Assays
2026-09-29
This scenario-based guide explains how Resazurin sodium salt, SKU B6098, can support reproducible cell proliferation, viability, and cytotoxicity workflows. It covers redox principles, DMSO compatibility, optimization, interpretation limits, and practical supplier selection for biomedical laboratories.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-09-29
The PKH26 Red Fluorescent Cell Linker Kit provides stable red labeling of cell membrane lipid regions for longitudinal cell tracing and proliferation studies. It is intended for membrane labeling in vitro and in vivo, not for intracellular targets or non-membrane structures.
-
7-Ethyl-10-hydroxycamptothecin Workflow Guide
2026-09-28
Build a mechanism-led SN-38 workflow that connects DNA topoisomerase I inhibition with cell-cycle and apoptosis readouts. This guide also shows how to test the FUBP1–FUSE finding from foundational research without overstating evidence from hepatocellular carcinoma models in colon cancer experiments.